CIK 0001815442 · Large accelerated filer
Kymera Therapeutics, Inc.
Sign in to watch- Ticker
- KYMR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812992166
- Phone
- 857-285-5314
- Business address
- 500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN, MA, 02472
- Former names
- Kymera Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,158,214
- in 2 filings, $3.4M under 10b5-1 plans
Net −$4,158,214. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-17 | Esposito Pamela Director | Option exercise 10b5-1 | +5,000 | $14.18 | $71K | 13,500 |
| 2024-09-17 | Esposito Pamela Director | Sale 10b5-1 | −6,350 | $47.75 | $303K | 7,150 |
| 2024-09-17 | Esposito Pamela Director | Sale 10b5-1 | −7,150 | $48.75 | $349K | 0 |
| 2024-09-17 | Esposito Pamela Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −8,500 | 31,627 | ||
| 2024-09-17 | Esposito Pamela Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 7,000 | ||
| 2024-08-26 | Albers Jeffrey W. Director | Option exercise 10b5-1 | +5,000 | $10.34 | $52K | 5,000 |
| 2024-08-26 | Albers Jeffrey W. Director | Sale 10b5-1 | −5,000 | $49.10 | $246K | 0 |
| 2024-08-26 | Albers Jeffrey W. Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 11,349 | ||
| 2024-08-21 | BAKER BROS. ADVISORS LP Director | Purchase · Prefunded Warrants | +347,572 | $40.75 | $14.2M | 919,001 |
| 2024-08-21 | BAKER BROS. ADVISORS LP Director | Purchase · Prefunded Warrants | +2,246,587 | $40.75 | $91.5M | 9,625,653 |
| 2024-08-20 | BAKER BROS. ADVISORS LP Director | Purchase | +1 | $46.41 | $46 | 5,516,986 |
| 2024-08-20 | BVF PARTNERS L P/IL Director | Purchase · Pre-Funded Warrants to Purchase Common Stock | +201,546 | $40.75 | $8.2M | 201,546 |
| 2024-08-20 | BVF PARTNERS L P/IL Director | Purchase · Pre-Funded Warrants to Purchase Common Stock | +156,742 | $40.75 | $6.4M | 156,742 |
Page 25 of 25 · 493 trades